HYRIMOZ

Google image searchProduct monograph

Active ingredient

adalimumab, 20 MG/0.4 ML

DIN: 02505258

Dosage form(s): SOLUTION

Route(s) of administration: SUBCUTANEOUS

Description: SINGLE-USE PREFILLED SYRINGE

Schedule: Prescription / Schedule D

Company: SANDOZ CANADA INCORPORATED

Date: 15-FEB-2021

ATC:

• L04 — IMMUNOSUPPRESSANTS (ATC, ATC/DDD, )
• L04A — IMMUNOSUPPRESSANTS (ATC, ATC/DDD)
• L04AB — Tumor necrosis factor alpha (TNF-alpha) inhibitors (ATC, ATC/DDD)
• L04AB04 — ADALIMUMAB (ATC/DDD)

Reference brand drug: Humira

External Links for Hyrimoz

Search on Google

• Hyrimoz side effects
• Hyrimoz dosage
• adalimumab side effects
• adalimumab dosage

Sandoz Canada Incorporated

Go to Sandoz website to see drug product details. Sometimes you can find hyrimoz photos and/or monograph. If you are a healthcare professional, you may need to enter your license number.